SELENON and breast carcinoma: In this study, we demonstrated that miR-193a-3p suppressed breast cancer cell growth by directly inhibiting CCND1, PLAU and SEPN1 expression, and suppressed breast cancer cell migration/invasion via silencing PLAU.